October 22nd 2024, 2:01pm
Nisha Mohindra, MD, and Christopher Towe, MD, discuss what early-stage non-small cell lung cancer treatment options have looked like in the past and a more recent treatment option, neoadjuvant therapy. Sponsored by Bristol Myers Squibb.
October 22nd 2024, 2:00pm
After Danielle Hicks introduces the panelists, Nisha Mohindra, MD, and Christopher Towe, MD, provide an overview of what an early-stage non-small cell lung cancer diagnosis means and how it is diagnosed. Sponsored by Bristol Myers Squibb.
October 21st 2024, 4:29pm
Panelists discuss how the landscape of treatment options for advanced prostate cancer has evolved, highlighting the importance of understanding current therapies to optimize patient outcomes.
Panelists discuss how sharing personal experiences with diagnosis helps illuminate the critical questions patients should ask their care teams and the pivotal role oncologists play in guiding treatment decisions.
October 21st 2024, 1:00pm
An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.
October 19th 2024, 2:00pm
An expert discussed how the understanding of resistance mechanisms can help care teams develop a global treatment strategy for EGFR-mutated non-small cell lung cancer.
October 18th 2024, 1:00pm
In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about other challenges of breast cancer outside of treatment.
In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about emotional well-being as a patient and survivor of breast cancer.
October 17th 2024, 1:00pm
Asking physicians how they perform less-invasive surgeries for breast cancer can help reassure patients that their lymphedema risk is kept in mind.
October 16th 2024, 9:00pm
In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about experiences with cancer from two breast cancer survivors.
“Chillin’ Out” and Finding Our Cancer Community
Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes
Optimal Jakafi Dosing Associated With Improved Outcomes in Myelofibrosis
Illuminating Compassion in Cancer Care